The University of Health Sciences (UHS) Punjab, has begun the preparation for a human trial of the potential coronavirus vaccine in Pakistan developed by Oxford University.
The UHS Vice-Chancellor, Dr. Javed, has said that the vaccine has been dispatched from the UK and will arrive in Pakistan in two weeks’ time.
He noted that that the registration process for volunteers has already started to enroll up to 20,000 volunteers. In the first phase of the pilot trial, at least 25 patients will be administered with the vaccine called AZD1222.
Last week, Dr. Akram had said that the varsity will require permission from the government of Pakistan, adding that it might take two months for the vaccine to be tested in Pakistan.
With so many countries trying to prepare the anti-coronavirus vaccine, Oxford University is among those showing promising results so far. The World Health Organization has described the AZD1222 vaccine as the leading candidate in a global race to halt the pandemic.
On July 20, the first results of the experimental vaccine prepared by AstraZeneca and Oxford University were released, showing an immune response in early-stage clinical trials against coronavirus.
The vaccine triggered no serious side effects and elicited antibody and T-cell immune responses. It showed impressive results among those who received two doses, intensifying hopes that it could be commercially available by the end of the year.